PMR Online access    |   tel. +48 12 618 90 00    |   E-mail: info@pmrcorporate.com
 


 

Homeless people die after trials of bird-flu vaccine


2008-07-10

Three doctors and six nurses from Dobra Praktyka Lekarska, a private healthcare clinic in Grudziadz (Pomorskie voivodship) are facing criminal prosecution after more than twenty homeless people died following medical trials for a vaccine to a bird-flu virus developed by Novartis.
The trials were conducted in 2007 on around 350 homeless and poor people. According to prosecutors, they involved an untried vaccine to H5N1, a highly-contagious  bird-flu virus. Twenty-one people died after being given the vaccine. Authorities claim that the alleged victims were told they were tested for a conventional flu vaccine.
Investigators are also probing the possibility that the medical staff may have also have deceived the pharmaceutical company that commissioned the trials. The suspects maintain that all those involved knew that the trial was for an anti-H5N1 drug and willingly participated.


Browse and search in our archive »


subscribe to PMR RSS NEWS channelsSubscribe to PMR RSS NEWS channels »




Free e-letter with overview of news, analyses and reports from the pharmaceutical and healthcare sector in Poland, Russia and CEE.
Latest news
 

Useful links         Privacy Policy
Copyright © 2013 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.